OlsAro raises €5m seed as salt-tolerant wheat nears the Bangladeshi market
Industrifonden leads OlsAro's €5m seed. Its non-GM wheat yielded up to 41% more than a moderately salt-tolerant variety in saline Bangladeshi soil.
OlsAro, a Swedish plant breeding company based in Gothenburg, announced a €5 million seed round on 14 October 2026. Industrifonden led the round and Nordic Foodtech VC co-led it, with existing backers Future Food Fund, PINC, AgFunder and GU Ventures all taking part. The round brings total funding to about €7.5 million, following a €2.5 million pre-seed in April 2024. OlsAro is a spinout from Lund University and the University of Gothenburg and is led by chief executive Elén Faxö.
The company breeds for salinity, a constraint that is spreading faster than most crop stresses and has no agronomic workaround once the salt is in the soil. Its lead wheat is designed to outperform conventional varieties between 4 and 8 deciSiemens per metre and to hold up to 10, and in saline conditions in Bangladesh it yielded up to 41 per cent more than a moderately salt-tolerant comparison variety. The breeding itself is conventional rather than transgenic, which matters commercially: Faxö has pointed out that developing commercial varieties without genetic modification lets the company enter its target markets without GM regulatory hurdles.
The money is meant to convert that single result into a platform. OlsAro calls it SeedAX, combining genetics, field data and AI-driven trait discovery to find and validate climate-resilience traits that seed companies can license repeatedly, with drought tolerance and nitrogen-use efficiency as the next programmes and rice among the cereals targeted for expansion. The commercial pipeline is already running outside Europe. Bangladesh is the lead market, where the wheat is in its second year of distinctness, uniformity and stability testing with partner Lal Teer Seed and a launch is targeted for 2027. In India, partner DCM Shriram tested three OlsAro lines at three saline sites in Uttar Pradesh and Bihar during the 2024-25 winter season, and further trials are running in Kenya, Pakistan, Egypt, Italy, Canada and Australia.
The investor side says something about where Nordic deep-tech capital is going. Industrifonden, which manages more than 5 billion Swedish krona, framed its decision around the underlying science rather than the commercial traction, with Sara Frykstrand Ångström saying what convinced the fund about OlsAro was the scientific work behind the company. Nordic Foodtech VC invests from a €42 million first fund raised in 2020 and a second fund launched in 2025, writing initial cheques of up to €2 million. Faxö put the purpose of the round plainly: "This round is about turning that capability into a platform seed companies can use repeatedly."
What this means for AgTech founders: the interesting move here is not the wheat, it is the choice of regulatory terrain. By breeding without transgenics, OlsAro gave up some of the speed and precision a gene-editing toolkit would have offered, and bought in exchange the ability to sell into Bangladesh, India, Pakistan, Kenya and Egypt without waiting for a GM approval that in several of those markets may never arrive. That is a deliberate trade of technical ceiling for addressable market, and at seed stage it is usually the right one, because a trait that cannot be sold anywhere is worth less than a smaller trait that can be sold in six countries. The second lesson is about what a €5 million round is actually for. OlsAro is not using it to scale a product, it is using it to turn one validated trait into a repeatable discovery engine that seed companies pay to use, which is the difference between a variety business and a platform business and also the difference between a trade sale and a licensing annuity. Founders with one strong field result should ask whether their next round is funding the second result or the machine that produces results, because investors are increasingly only willing to underwrite the second of those at this size. The caution: the yield figure comes from one country against one comparison variety, the Bangladeshi launch is still a year out and subject to variety registration, and SeedAX has no disclosed licensing revenue yet.
OlsAro raises €5m seed as salt-tolerant wheat nears the Bangladeshi market
Industrifonden leads the round for the Gothenburg company, with Nordic Foodtech VC co-leading. Its non-GM wheat yielded up to 41 per cent more than a moderately salt-tolerant variety under saline conditions in Bangladesh.
OlsAro, a Swedish plant breeding company based in Gothenburg, announced a €5 million seed round on 14 October 2026. Industrifonden led the round and Nordic Foodtech VC co-led it, with existing backers Future Food Fund, PINC, AgFunder and GU Ventures all taking part. The round brings total funding to about €7.5 million, following a €2.5 million pre-seed in April 2024. OlsAro is a spinout from Lund University and the University of Gothenburg and is led by chief executive Elén Faxö.
The company breeds for salinity, a constraint that is spreading faster than most crop stresses and has no agronomic workaround once the salt is in the soil. Its lead wheat is designed to outperform conventional varieties between 4 and 8 deciSiemens per metre and to hold up to 10, and in saline conditions in Bangladesh it yielded up to 41 per cent more than a moderately salt-tolerant comparison variety. The breeding itself is conventional rather than transgenic, which matters commercially: Faxö has pointed out that developing commercial varieties without genetic modification lets the company enter its target markets without GM regulatory hurdles.
The money is meant to convert that single result into a platform. OlsAro calls it SeedAX, combining genetics, field data and AI-driven trait discovery to find and validate climate-resilience traits that seed companies can license repeatedly, with drought tolerance and nitrogen-use efficiency as the next programmes and rice among the cereals targeted for expansion. The commercial pipeline is already running outside Europe. Bangladesh is the lead market, where the wheat is in its second year of distinctness, uniformity and stability testing with partner Lal Teer Seed and a launch is targeted for 2027. In India, partner DCM Shriram tested three OlsAro lines at three saline sites in Uttar Pradesh and Bihar during the 2024-25 winter season, and further trials are running in Kenya, Pakistan, Egypt, Italy, Canada and Australia.
The investor side says something about where Nordic deep-tech capital is going. Industrifonden, which manages more than 5 billion Swedish krona, framed its decision around the underlying science rather than the commercial traction, with Sara Frykstrand Ångström saying what convinced the fund about OlsAro was the scientific work behind the company. Nordic Foodtech VC invests from a €42 million first fund raised in 2020 and a second fund launched in 2025, writing initial cheques of up to €2 million. Faxö put the purpose of the round plainly: "This round is about turning that capability into a platform seed companies can use repeatedly."
What this means for AgTech founders: the interesting move here is not the wheat, it is the choice of regulatory terrain. By breeding without transgenics, OlsAro gave up some of the speed and precision a gene-editing toolkit would have offered, and bought in exchange the ability to sell into Bangladesh, India, Pakistan, Kenya and Egypt without waiting for a GM approval that in several of those markets may never arrive. That is a deliberate trade of technical ceiling for addressable market, and at seed stage it is usually the right one, because a trait that cannot be sold anywhere is worth less than a smaller trait that can be sold in six countries. The second lesson is about what a €5 million round is actually for. OlsAro is not using it to scale a product, it is using it to turn one validated trait into a repeatable discovery engine that seed companies pay to use, which is the difference between a variety business and a platform business and also the difference between a trade sale and a licensing annuity. Founders with one strong field result should ask whether their next round is funding the second result or the machine that produces results, because investors are increasingly only willing to underwrite the second of those at this size. The caution: the yield figure comes from one country against one comparison variety, the Bangladeshi launch is still a year out and subject to variety registration, and SeedAX has no disclosed licensing revenue yet.
